Search

17 May 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns.

19 September 2022 - Find out the simple things you can do to help support people living with dementia

3 August 2023 - All students aged approximately 12 and 13 will be offered the HPV vaccine for free in schools as part of the National Immunisation Program. The video explains the importance of the vaccine.

19 September 2022 - Professor Michael Kidd, Deputy Chief Medical Officer answers some of the common questions around dementia.

27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Gaucher disease (type 1) under the Life Saving Drugs Program.

27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type IVA (MPS IVA) under the Life Saving Drugs Program.

27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type II (MPS II) under the Life Saving Drugs Program.

27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type I (MPS I) under the Life Saving Drugs Program.

27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type VI (MPS VI) under the Life Saving Drugs Program.

28 September 2023 - COVID-19 can be fatal for patients with heart disease. Even patients without heart disease can suffer damage to their heart. Bioengineer Professor James Hudson has found a drug which could protect our hearts from this damage.